No effect of atypical antipsychotic drugs on weight gain and risk of developing type II diabetes or lipid abnormalities among nursing home elderly patients with Alzheimer's disease.

Rondanelli, M; Sarra, S; Antoniello, N; Mansi, V; Govoni, S; Falvo, F; Solerte, S B; Ferrari, E

Rondanelli, M; Sarra, S; Antoniello, N; Mansi, V; Govoni, S; Falvo, F; Solerte, S B; Ferrari, E.

Affiliation

Rondanelli M; Azienda Servizi alla Persona, Istituzioni Assistenziali Riunite (IIAARR), Santa Margherita Institute, Via Emilia 32, 27100 Pavia, Italy. serv.nutrizione@asppavia.it

Minerva Med ; 97(2): 147-51, 2006 Apr.

Article in En | MEDLINE | ID: mdl-16760853

Subject(s)

Alzheimer Disease/psychology; Antipsychotic Agents/adverse effects; Blood Glucose/drug effects; Lipids/blood; Weight Gain; Aged; Aged, 80 and over; Alzheimer Disease/blood; Benzodiazepines/adverse effects; Dibenzothiazepines/adverse effects; Female; Humans; Male; Mental Disorders/drug therapy; Nursing Homes; Olanzapine; Quetiapine Fumarate; Retrospective Studies; Risperidone/adverse effects

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antipsychotic Agents / Blood Glucose / Weight Gain / Alzheimer Disease / Lipids Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Aged / Aged80 / Female / Humans / Male Language: En Journal: Minerva Med Year: 2006 Document type: Article

Search on Google

XML

PubMed Links